$5.66 4.9%
Price vs. AI Score (Last 150 days)
Data gathered: December 1

Data Bits

Data Bits Value / Change Benchmark
Job Posts 1 0%
Sentiment 100 0%
Webpage traffic 21,000 -14.2%
Employee Rating 65 0%
Linkedin Employees 162 N/A
Patents 45 2.3%
4chan Mentions 0% N/A
Stocktwits Mentions 9 -18.2%
Stocktwits Subscribers 2,141 -0.1%
Twitter Followers 6,391 0.1%
News Mentions 0%
Reddit Mentions 0%
Business outlook 40 0%

AI Score

Sign up to see AI score

Brand Score Sign up
Employment Score Sign up
User Growth Score Sign up
Fundamental Score Sign up

In the news

About Caribou Biosciences

Caribou Biosciences, Inc., a clinical-stage biopharmaceutical company, engages in the development of genome-edited allogeneic cell therapies for the treatment of hematologic malignancies and solid tumors in the United States and internationally.

Caribou Biosciences
Price $5.66
Target Price Sign up
Market Cap $527M
Dividend Yield 0
Industry Medical Devices

Financial performance View All

Revenue Cost of Revenue Gross Profit Net Income ebitda
Q3 '2324M9.7M14M-10M-15M
Q2 '233.8M10M-6.4M-30M-33M
Q1 '233.5M8.9M-5.4M-28M-31M
Q4 '228.3M8.5M-240,000-27M-31M
Q3 '223.3M9.8M-6.5M-27M-26M

Insider Transactions

Rizvi Syed Ali-aamir filed to sell 59,373 shares at $6.3.
January 20 '23
The analytics provided are estimates and not a substitute for professional advice. All investments involve risks, including possible capital loss.
About Us

AltIndex revolutionizes investing with advanced alternative data analytics, smart insights, and stock alerts, presented in an easy-to-use dashboard powered by comprehensive company data from across the internet.

Legal Disclaimer
The information provided by AltIndex is solely for informational purposes and not a substitute for professional financial advice. Investing in financial markets carries inherent risks, and past performance doesn't guarantee future results. It's crucial to do your research, consult with financial experts, and align your financial objectives and risk tolerance before investing. AltIndex creators and operators are not liable for any financial losses incurred from using this information. Users should exercise caution, seek professional advice, and be prepared for the risks involved in trading and investing in financial assets, only investing what they can afford to lose. The information in this application, derived from publicly available data, is believed to be reliable but may not always be accurate or current. Users should verify information independently and not solely rely on this application for financial decisions. By using AltIndex, you acknowledge that it doesn't offer financial advice and agree to consult a qualified financial advisor before making investment decisions.

© 2023 AltIndex. All rights reserved.